A specific protein in the body may be the key to overcoming the increasing problem of resistance to HIV drugs, researchers say.
HIV drugs known as protease inhibitors has been suggested by a team of researchers from Harvard Medical School, Boston ...
... tiny bits of gold to a failed HIV drug rekindle the drug’s ability to stop the virus ... , the compound was unable to prevent HIV infection, indicating that the multivalency of the drug was important for its activity. “We’ve ...
... ignored parts of the HIV genome play an important role in the development of drug resistance in AIDS ... genotype testing is now widely established in HIV drug resistance screening. However, for technical ...
... . Disheartened by the failures of vaccines and microbicides in blocking HIV transmission, some AIDS researchers are now touting a third possibility: using existing HIV drugs prophylactically ...
... , factors that dictate the pharmacokinetics of anti-HIV drugs need to be accounted for in order to have HAART efficacy ... to target the MRP-transporters. Our studies using the anti-HIV drugs, saquinavir and zidovudine, clearly implicated ...
... from the class previously. Unlike earlier HIV drugs that target the virus, maraviroc acts on the human ... resistance, medicines lose their ability to fight HIV. Some drugs become less effective while ...
... for drug development. APOBEC-3G is present in every human cell. It is capable of stopping HIV ... . "This understanding provides a platform for designing anti-HIV drugs." If APOBEC-3G works so ... binds to APOBEC-3G. The knowledge could be used to design drugs that would prevent Vif from binding and allow ...
... adherence to life saving antiretroviral drugs among African HIV patients should be understood ... . In Sub-Saharan Africa, adherence to these anti-HIV drugs improves patients' health, which is also a strong ...
ROME, Feb. 2 (UPI) -- The co-discoverer of the HIV virus, Luc Montagnier, says poor nations need better access to HIV drugs.
... immune system surveillance and escape from anti-HIV drugs. "Macrophages are these little factories producing ... disease — are an obvious target for HIV drug development because they die soon after infection, and are readily ...
WASHINGTON (AP) -- The Food and Drug Administration says an HIV drug from Pfizer appears safe for expanded use in patients who have not taken other drugs to combat the virus....
... that show promise as novel treatments for the disease. HIV drug discovery efforts have met with little ... new approach that could be useful to deal with issues such as drug-resistant HIV strains, and may slow the progression to AIDS ...
... . Their work was published this week in Cell. "Many anti-HIV drugs are designed to stop the process of DNA ... they're different." In addition to its relevance to anti-HIV drug design, Yin's research is also helping ...
A federal bill that would make it easier to sell cheap HIV drugs to developing countries has passed second reading in the House of Commons.
